Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2007-07-10
Kwon, Brian (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S310000, C514S404000
Reexamination Certificate
active
10451300
ABSTRACT:
Invented are non-peptide TPO mimetics. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected substituted thiosemicarbazone derivative.
REFERENCES:
patent: 5376451 (1994-12-01), Albin et al.
patent: 6552008 (2003-04-01), Duffy et al.
patent: 6720345 (2004-04-01), Luengo et al.
patent: 286580 (1991-01-01), None
patent: 290184 (1991-05-01), None
patent: 433526 (1991-06-01), None
patent: WO 99/11262 (1999-03-01), None
patent: WO 00/28987 (2000-05-01), None
patent: WO 01/34585 (2001-05-01), None
(“Arylhydrozones and Phenylsemicarbazones of 2-aminobenzophenones as Antithrombotic agents”, Andronati et al., Pharmazie, abstract, 1995, 50(9), 632-3.
“Synthesis and Biological Evaluation of a New Series of Potential Beta Blockers with Dual Pharmacological Actions”, Viswanathan et al., Indian Drugs, abstact, 1990, 27(1), 513-15.
Duffy Kevin J.
Jenkins Julian
Luengo Juan I.
Miller Stephen G.
Price Alan T.
Dustman Wayne J.
Kinzig Charles M
Kwon Brian
Ligand Pharmaceutical
SmithKline Beecham Corporation
LandOfFree
Thrombopoietin mimetics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombopoietin mimetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombopoietin mimetics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3721983